327 related articles for article (PubMed ID: 16010543)
1. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
Olmstead MC; Burns LH
Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543
[TBL] [Abstract][Full Text] [Related]
2. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
Leri F; Burns LH
Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
5. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
6. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.
Shippenberg TS; Chefer VI; Thompson AC
Biol Psychiatry; 2009 Jan; 65(2):169-74. PubMed ID: 18950747
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
Wu Y; Li Y; Yang X; Sui N
Addict Biol; 2014 Jan; 19(1):5-15. PubMed ID: 22458530
[TBL] [Abstract][Full Text] [Related]
8. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
[TBL] [Abstract][Full Text] [Related]
10. Alterations of naltrexone-induced conditioned place avoidance by pre-exposure to high fructose corn syrup or heroin in Sprague-Dawley rats.
Daniels S; Marshall P; Leri F
Psychopharmacology (Berl); 2016 Feb; 233(3):425-33. PubMed ID: 26514556
[TBL] [Abstract][Full Text] [Related]
11. Morphine and ethanol pretreatment effects on expression and extinction of ethanol-induced conditioned place preference and aversion in mice.
Cunningham CL; Bakner L; Schuette LM; Young EA
Psychopharmacology (Berl); 2021 Jan; 238(1):55-66. PubMed ID: 32980910
[TBL] [Abstract][Full Text] [Related]
12. Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats.
Kelsey JE; Arnold SR
Behav Neurosci; 1994 Dec; 108(6):1119-27. PubMed ID: 7893404
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
White DA; Holtzman SG
Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
[TBL] [Abstract][Full Text] [Related]
14. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
Crain SM; Shen KF
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
[TBL] [Abstract][Full Text] [Related]
16. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
17. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
[TBL] [Abstract][Full Text] [Related]
18. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal-like effects of pentylenetetrazol and valproate in the naive organism: a model of motivation produced by opiate withdrawal?
Mucha RF; Fassos FF; Perl FM
Drug Alcohol Depend; 1995 Jul; 39(1):1-6. PubMed ID: 7587968
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats.
Rutten K; van der Kam EL; De Vry J; Tzschentke TM
Pharmacology; 2011; 87(5-6):286-96. PubMed ID: 21577043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
